Laura H. Hendrix

1.1k total citations
39 papers, 733 citations indexed

About

Laura H. Hendrix is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Laura H. Hendrix has authored 39 papers receiving a total of 733 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 12 papers in Oncology and 7 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Laura H. Hendrix's work include Prostate Cancer Diagnosis and Treatment (15 papers), Prostate Cancer Treatment and Research (13 papers) and Global Cancer Incidence and Screening (7 papers). Laura H. Hendrix is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (15 papers), Prostate Cancer Treatment and Research (13 papers) and Global Cancer Incidence and Screening (7 papers). Laura H. Hendrix collaborates with scholars based in United States, Germany and United Kingdom. Laura H. Hendrix's co-authors include Ronald C. Chen, Aaron D. Falchook, Ian M. Allen, Trevor J. Royce, William A. Stokes, Paul A. Godley, Reshma Jagsi, Ramzi G. Salloum, Andrew Z. Wang and William R. Carpenter and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Laura H. Hendrix

37 papers receiving 722 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Laura H. Hendrix United States	15	313	273	149	108	97	39	733
Ryan McCabe United States	12	401 1.3×	180 0.7×	126 0.8×	118 1.1×	89 0.9×	34	707
Jaclyn Beca Canada	15	284 0.9×	204 0.7×	251 1.7×	61 0.6×	101 1.0×	58	691
Tzy-Mey Kuo United States	12	224 0.7×	366 1.3×	113 0.8×	123 1.1×	52 0.5×	16	676
Noam A. VanderWalde United States	16	269 0.9×	242 0.9×	104 0.7×	247 2.3×	98 1.0×	48	822
Vinayak Muralidhar United States	20	435 1.4×	752 2.8×	157 1.1×	183 1.7×	86 0.9×	65	1.1k
Michelle C. Salazar United States	16	363 1.2×	483 1.8×	80 0.5×	154 1.4×	72 0.7×	38	829
Patrick Bowden Australia	8	194 0.6×	263 1.0×	50 0.3×	103 1.0×	53 0.5×	19	621
Joan Prades Spain	8	229 0.7×	103 0.4×	87 0.6×	68 0.6×	43 0.4×	21	458
Junaid Nabi United States	12	205 0.7×	202 0.7×	82 0.6×	141 1.3×	76 0.8×	52	586
Richard Simcock United Kingdom	12	298 1.0×	120 0.4×	86 0.6×	70 0.6×	57 0.6×	43	623

Countries citing papers authored by Laura H. Hendrix

Since Specialization

Citations

This map shows the geographic impact of Laura H. Hendrix's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura H. Hendrix with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura H. Hendrix more than expected).

Fields of papers citing papers by Laura H. Hendrix

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura H. Hendrix. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura H. Hendrix. The network helps show where Laura H. Hendrix may publish in the future.

Co-authorship network of co-authors of Laura H. Hendrix

This figure shows the co-authorship network connecting the top 25 collaborators of Laura H. Hendrix. A scholar is included among the top collaborators of Laura H. Hendrix based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura H. Hendrix. Laura H. Hendrix is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sheppard, John D., Paul Karpecki, Michael B. Raizman, et al.. (2023). Does Dry Eye Disease Severity Impact Efficacy of Varenicline Solution Nasal Spray on Sign and Symptom Treatment Outcomes?. Optometry and Vision Science. 100(2). 164–169. 7 indexed citations

Schallhorn, Julie M., Jeffrey Nau, Marian S. Macsai, et al.. (2023). OC-01 (Varenicline Solution) Nasal Spray for the Treatment of Dry Eye Disease Signs and Symptoms in Subjects with Autoimmune Disease: Integrated Data from ONSET-1 and ONSET-2. Clinical ophthalmology. Volume 17. 725–734. 2 indexed citations

Katz, James A, Laura M. Periman, Enrica Sarnicola, et al.. (2022). Bilateral Effect of OC-01 (Varenicline Solution) Nasal Spray for Treatment of Signs and Symptoms in Individuals with Mild, Moderate, and Severe Dry Eye Disease. Clinical Therapeutics. 44(11). 1463–1470. 5 indexed citations

Visco, Denise M., et al.. (2022). Matching-adjusted indirect comparison of phase 3 clinical trial outcomes: OC-01 (varenicline solution) nasal spray and cyclosporine a 0.05% ophthalmic emulsion for the treatment of dry eye disease. Journal of Managed Care & Specialty Pharmacy. 28(8). 892–902. 4 indexed citations

Ryser, Marc D., et al.. (2019). Incidence of Ductal Carcinoma In Situ in the United States, 2000–2014. Cancer Epidemiology Biomarkers & Prevention. 28(8). 1316–1323. 23 indexed citations

Moss, Haley, et al.. (2019). Simulated Costs of the ASCO Patient-Centered Oncology Payment Model in Medicare Beneficiaries With Newly Diagnosed Advanced Ovarian Cancer. Journal of Oncology Practice. 15(12). e1018–e1027. 1 indexed citations

Epplein, Meira, Julia Butt, Yang Zhang, et al.. (2018). Validation of a Blood Biomarker for Identification of Individuals at High Risk for Gastric Cancer. Cancer Epidemiology Biomarkers & Prevention. 27(12). 1472–1479. 19 indexed citations

Khan, Saira, Jianwen Cai, Matthew E. Nielsen, et al.. (2016). The association of diabetes and obesity with prostate cancer aggressiveness among Black Americans and White Americans in a population-based study. Cancer Causes & Control. 27(12). 1475–1485. 9 indexed citations

Diao, Kevin, Ramsankar Basak, Laura H. Hendrix, et al.. (2016). Patient-reported quality of life during definitive and postprostatectomy image-guided radiation therapy for prostate cancer. Practical Radiation Oncology. 7(2). e117–e124. 9 indexed citations

10.

Caster, Joseph M., Aaron D. Falchook, Laura H. Hendrix, & Ronald C. Chen. (2015). Risk of Pathologic Upgrading or Locally Advanced Disease in Early Prostate Cancer Patients Based on Biopsy Gleason Score and PSA: A Population-Based Study of Modern Patients. International Journal of Radiation Oncology*Biology*Physics. 92(2). 244–251. 39 indexed citations

11.

Chen, Ronald C., William R. Carpenter, Laura H. Hendrix, et al.. (2014). Receipt of Guideline-Concordant Treatment in Elderly Prostate Cancer Patients. International Journal of Radiation Oncology*Biology*Physics. 88(2). 332–338. 23 indexed citations

12.

Jagsi, Reshma, et al.. (2014). Adoption of Hypofractionated Radiation Therapy for Breast Cancer After Publication of Randomized Trials. International Journal of Radiation Oncology*Biology*Physics. 90(5). 1001–1009. 84 indexed citations

13.

Royce, Trevor J., Laura H. Hendrix, William A. Stokes, Ian M. Allen, & Ronald C. Chen. (2014). Cancer Screening Rates in Individuals With Different Life Expectancies. JAMA Internal Medicine. 174(10). 1558–1558. 116 indexed citations

14.

Chen, Ronald C., Aaron D. Falchook, Laura H. Hendrix, & Reshma Jagsi. (2014). Adoption of hypofractionated radiotherapy for early-stage invasive breast cancer after publication of randomized trials.. Journal of Clinical Oncology. 32(15_suppl). 6522–6522. 3 indexed citations

15.

Church, Jessica A., Robert Adams, Laura H. Hendrix, et al.. (2013). National study to determine the comfort levels of radiation therapists and medical dosimetrists to report errors. Practical Radiation Oncology. 3(4). e165–e170. 11 indexed citations

16.

Hendrix, Laura H., et al.. (2013). Guideline-discordant androgen deprivation therapy in localized prostate cancer: patterns of use in the medicare population and cost implications. Annals of Oncology. 24(5). 1338–1343. 23 indexed citations

17.

Falchook, Aaron D., Ramzi G. Salloum, Laura H. Hendrix, & Ronald C. Chen. (2013). Use of Bone Scan During Initial Prostate Cancer Workup, Downstream Procedures, and Associated Medicare Costs. International Journal of Radiation Oncology*Biology*Physics. 89(2). 243–248. 38 indexed citations

18.

Chen, Ronald C., Matthew E. Nielsen, Bryce B. Reeve, et al.. (2013). Perceptions regarding prostate cancer (CaP) treatment options: Results from the North Carolina Prostate Cancer Comparative Effectiveness and Survivorship Study (NC ProCESS).. Journal of Clinical Oncology. 31(15_suppl). 6530–6530. 3 indexed citations

19.

Holmes, Jordan A., Andrew Z. Wang, Karen E. Hoffman, et al.. (2012). Is Primary Prostate Cancer Treatment Influenced by Likelihood of Extraprostatic Disease? A Surveillance, Epidemiology and End Results Patterns of Care Study. International Journal of Radiation Oncology*Biology*Physics. 84(1). 88–94. 9 indexed citations

20.

Allen, Ian M., Laura H. Hendrix, Trevor J. Royce, et al.. (2012). Prostate-specific antigen (PSA) screening in the United States: Patterns of use and PSA outcomes in screened versus unscreened men.. Journal of Clinical Oncology. 30(15_suppl). 4658–4658. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact